Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
IFOM ETS - The AIRC Institute of Molecular Oncology
Imperial College London
City of Hope Medical Center
Dana-Farber Cancer Institute
University of Nebraska
University of Nebraska
NanOlogy, LLC
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
University of Kentucky
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Celgene
Barbara Ann Karmanos Cancer Institute
Shanghai Changzheng Hospital
Georgetown University
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Children's Oncology Group
University of Arkansas
Roswell Park Cancer Institute
Roswell Park Cancer Institute
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Virginia Commonwealth University
Hoosier Cancer Research Network
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
SCRI Development Innovations, LLC
Roswell Park Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Children's Oncology Group
Roswell Park Cancer Institute
Radiation Therapy Oncology Group
Vanderbilt-Ingram Cancer Center